Pioneering Medical Innovations
Acquisition expands portfolio of men’s health in-office procedures with adjunctive therapy for prostate cancer patients Sep 6, 2018 MARLBOROUGH, Mass., Sept.
Lower penile bulb radiation dose may be associated with ability to maintain sexual function and potency BEDFORD, Mass.–(BUSINESS WIRE)–Augmenix, Inc.,
FDA clearance in hand, Augmenix is formulating U.S. commercial sales and insurance reimbursement plans for a medical gel designed to
First-of-its-kind Treatment Offers Significant Clinical Benefits to Prostate Cancer Patients Undergoing Radiotherapy WALTHAM, Mass.—April 2, 2015—Augmenix, Inc., a privately held
Agreement creates opportunity for improving outcomes in radiation oncology PALO ALTO, Calif. and WALTHAM, Mass., May 12, 2011 /PRNewswire/ —
WALTHAM, Mass., Aug. 11 /PRNewswire/ — Augmenix, Inc. announced today that Prof. Michael Eble and Dr. Michael Pinkawa of the
WALTHAM, Mass., Oct. 16 /PRNewswire/ — Augmenix announced today that it has closed a $6.1 million Series B financing. The